Ocaro Pharmaceuticals
Greensboro, US · Delaware corporation
Founders & leadership
RJ
Roland JohnsonNamed on SEC filing
LS
Lanty SmithNamed on SEC filing
BY
Bill YatesNamed on SEC filing
EB
Eric BarnettNamed on SEC filing
AJ
Andy JaneNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$610K disclosed across 1 round · 2022
▶$610KraisedNov 2022 · 12 investors · PharmaceuticalsRule 506(b)
▶$610KraisedNov 2022 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Roland JohnsonExecutive Officer, Director
- Lanty SmithDirector
- Bill YatesDirector
- Eric BarnettExecutive Officer
- Andy JaneDirector
- Offering amount
- $610K
- Amount sold
- $610K
- Minimum investment
- $30K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Ocaro Pharmaceuticals raised?
- Ocaro Pharmaceuticals has disclosed $610K raised across 1 round.
- Where is Ocaro Pharmaceuticals headquartered?
- Ocaro Pharmaceuticals is headquartered in Greensboro, US.